| Name | N-Boc-3-mesyloxypiperidine |
|---|---|
| Synonyms |
2-Methyl-2-propanyl 3-[(methylsulfonyl)oxy]-1-piperidinecarboxylate
tert-Butyl 3-((methylsulfonyl)oxy)piperidine-1-carboxylate tert-Butyl 3-Methylsulfonyloxypiperidine-1-carboxylate 3-methanesulfonyloxy-N-t-butoxycarbonylpiperidine 1-Piperidinecarboxylic acid, 3-[(methylsulfonyl)oxy]-, 1,1-dimethylethyl ester 1-Boc-3-methanesulphonyloxypiperidine tert-Butyl 3-[(methylsulfonyl)oxy]piperidine-1-carboxylate tert-Butyl 3-[(methylsulfonyl)oxy]-1-piperidinecarboxylate tert-Butyl 3-Methylsulfonyloxypiperidin-1-carboxylate 1-tert-butoxycarbonylpiperid-3-yl methanesulfonate |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 407.2±34.0 °C at 760 mmHg |
| Molecular Formula | C11H21NO5S |
| Molecular Weight | 279.353 |
| Flash Point | 200.1±25.7 °C |
| Exact Mass | 279.114044 |
| PSA | 81.29000 |
| LogP | 0.64 |
| Vapour Pressure | 0.0±0.9 mmHg at 25°C |
| Index of Refraction | 1.500 |
| HS Code | 2933399090 |
|---|
|
~99%
129888-60-4 |
| Literature: VERTEX PHARMACEUTICALS INCORPORATED; Charrier, Jean-Damien; Durrant, Steven John; Knegtel, Ronald Patent: US2013/115310 A1, 2013 ; Location in patent: Paragraph 0248; 0249 ; |
|
~90%
129888-60-4 |
| Literature: BIOGEN IDEC MA INC.; SUNESIS PHARMACEUTICALS, INC.; HOPKINS, Brian, T.; SCOTT, Daniel; CONLON, Patrick; JENKINS, Tracy, J.; POWELL, Noel; GUAN, Bing; CURERVO, Julio, H.; WANG, Deping; TAVERAS, Art Patent: WO2012/58645 A1, 2012 ; Location in patent: Page/Page column 210 ; WO 2012/058645 A1 |
|
~94%
129888-60-4 |
| Literature: The United States of America as represented by the Department of Health and Human Services Patent: US5571832 A1, 1996 ; US 5571832 A |
|
~%
129888-60-4 |
| Literature: Journal of Medicinal Chemistry, , vol. 35, # 23 p. 4334 - 4343 |
|
~%
129888-60-4 |
| Literature: Journal of Medicinal Chemistry, , vol. 35, # 23 p. 4334 - 4343 |
| Precursor 6 | |
|---|---|
| DownStream 5 | |
| HS Code | 2933399090 |
|---|---|
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |